NEW YORK (GenomeWeb) – Eurofins Scientific announced today that it has opened a new manufacturing and genomic testing services facility in Louisville, Kentucky.
According to the company, the facility will function as its central genomics lab in North America, handling custom production of DNA and RNA oligonucleotides, synthetic gene synthesis, and genomic services including DNA sequencing, synthetic biology, and next-generation sequencing.
The company said it also plans to introduce new synthesis technology in the facility, and that the site will also house other activities such as food and microbiology testing.
Further, the new site is accessible to most major cities in the US, which should cut down on the turnaround time for delivery of genomic results and services, Eurofins added.
"Our ambition is to make it the most modern and innovative facility of its kind in the world. This state-of-the-art laboratory reflects the [company's] commitment to quality, innovation, and to contributing to the advancement of scientific research and health sciences around the globe," CEO Gilles Martin said in a statement.